Dynamics of Hepatitis C Viremia

Dynamics of hepatitis C viremia.

To the Editor—The recent report of Yasui et al. [1] describing the dynamics of hepatitis C viremia following interferon-a administration contains some intriguing information regarding the ratio of core protein to hepatitis C virus (HCV) RNA. First, there are very few laboratories that can measure the concentration of HCV core protein in serum. Thus, the information provided in table 1 of [1], g...

The effect of transcatheter arterial chemoembolization on hepatitis C viremia.

To the Editor, We read with great interest the article by Sansonno et al. [1] on transarterial chemoembolization (TACE) plus sorafenib in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). The authors did not provide information on the HCV kinetics of patients receiving this treatment intervention because of the oncologic nature of the study. Hepatitis B virus (HBV) a...

Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study.

Hepatitis C virus (HCV) is associated with the development of cirrhosis and hepatocellular carcinoma. We recently found that bovine lactoferrin, a milk protein belonging to the iron transporter family, effectively prevented HCV infection in cultured human hepatocytes (PH5CH8). We tested the hypothesis that lactoferrin inhibits HCV viremia in patients with chronic hepatitis C. Eleven patients wi...

Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.

Hepatitis C virus RNA viremia in Central Africa.

of age. Sex was not significantly associated (mean male to female sex ratio was 32.4:18 for S. typhi and 15.8:10.6 for S. paratyphi A). S. typhi has become increasingly sensitive to amoxycillin, chloramphenicol, and gentamicin, increasing from 75.1% in 1994 to 96.6% in 1998 for amoxycillin, from 71.9% in 1994 to 91.6% in 1998 for chloramphenicol, and from 96.4% to 100% for gentamicin. S. paraty...